Home
Market Capitalization of J B Chemicals & Pharmaceuticals Ltd

J B Chemicals & Pharmaceuticals Ltd
NSE: JBCHEPHARM
Market Cap
Key Highlights
- The Market Cap of J B Chemicals & Pharmaceuticals Ltd is ₹ 24981 crore as of 21 Feb 25 .
- The Latest Trading Price of J B Chemicals & Pharmaceuticals Ltd is ₹ 1605 as of 21 Feb 15:30 .
- The Dividend Payouts of J B Chemicals & Pharmaceuticals Ltd changed from ₹ 8 on Aug 12, 2022 to ₹ 8.5 on Feb 07, 2025 . This represents a CAGR of 1.02% over 6 years.

J B Chemicals & Pharmaceuticals Ltd
NSE: JBCHEPHARM
Share Price
Market Price of J B Chemicals & Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 1605.45 |
20 Feb 2025 | 1630.45 |
19 Feb 2025 | 1673.35 |
18 Feb 2025 | 1613.75 |
17 Feb 2025 | 1644.55 |
14 Feb 2025 | 1666.4 |
13 Feb 2025 | 1685.6 |
12 Feb 2025 | 1627.3 |
11 Feb 2025 | 1611.5 |
10 Feb 2025 | 1678.5 |
SWOT Analysis Of J B Chemicals & Pharmaceuticals Ltd
BlinkX Score for J B Chemicals & Pharmaceuticals Ltd
Asset Value vs Market Value of J B Chemicals & Pharmaceuticals Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of J B Chemicals & Pharmaceuticals Ltd
Historical P/E Ratio of J B Chemicals & Pharmaceuticals Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of J B Chemicals & Pharmaceuticals Ltd
Historical Revenue of J B Chemicals & Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of J B Chemicals & Pharmaceuticals Ltd
Historical EBITDA of J B Chemicals & Pharmaceuticals Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of J B Chemicals & Pharmaceuticals Ltd
Historical Net Profit of J B Chemicals & Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of J B Chemicals & Pharmaceuticals Ltd
Historical Dividend Payouts of J B Chemicals & Pharmaceuticals Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payouts of J B Chemicals & Pharmaceuticals Ltd
About J B Chemicals & Pharmaceuticals Ltd
- J B Chemicals & Pharmaceuticals (JBC) was originally promoted and incorporated in Maharashtra by J B Mody as J B Mody Chemicals & Pharmaceuticals in December 18th, 1976.
- The Company is engaged in the business of manufacturing and marketing of diverse range of pharmaceuticals formulations, herbal remedies and APIs.
- The company has manufacturing units at Thane, Belapur, Ankleshwar, Panoli and Daman.
- The bulk drug plant at Panoli and formulation plant at Daman became operational in Apr.'95.
- Products like metrogyl, rantac (a ranitidine-based formulation), and nicardia (a cardiac care medicine) form a significant part of the company's sales.
J B Chemicals & Pharmaceuticals Ltd News Hub
J B Chemicals & Pharmaceuticals Ltd soars 1.09%, Gains for third straight session
J B Chemicals & Pharmaceuticals Ltd is up for a third straight session in a row. The stock is quotin
Read more
14 Aug 24
J B Chemicals & Pharmaceuticals allots 11,500 equity shares under ESOS
J B Chemicals & Pharmaceuticals has allotted 11,500 equity shares under ESOS on 08 August 2024. Cons
Read more
08 Aug 24
J B Chemicals & Pharmaceuticals consolidated net profit rises 24.25% in the June 2024 quarter
Net profit of J B Chemicals & Pharmaceuticals rose 24.25% to Rs 176.83 crore in the quarter ended Ju
Read more
08 Aug 24
J B Chemicals & Pharmaceuticals allots 69,850 equity shares under ESOS
J B Chemicals & Pharmaceuticals has allotted 69,850 equity shares under ESOS on 26 August 2024. Cons
Read more
27 Aug 24